Search Results - Tyler Shugg
- Showing 1 - 4 results of 4
-
1
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk by Tyler Shugg, Katherine A. Gallaway, Nick Powell, Todd C. Skaar, Steven M. Bray, Leigh Anne Stout, Abi Colwell, Cynthia D. Brown, James E. Slaven, Emma M. Tillman
Published 2025Get full text
Artículo Open Access -
2
Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs by Hyunwoo Koo, Tayler B. Smith, John T. Callaghan, Wilberforce Osei, Steven M. Bray, Emma M. Tillman, Mya T. Tran, Christopher A. Fausel, Bryan P. Schneider, Tyler Shugg, Todd C. Skaar
Published 2025Get full text
Artículo Open Access -
3
Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned by Tyler Shugg, Emma M. Tillman, Amy M. Breman, Jennelle C. Hodge, Christine A. McDonald, Reynold C. Ly, Elizabeth J. Rowe, Wilberforce Osei, Tayler B. Smith, Peter H. Schwartz, John T. Callaghan, Victoria M. Pratt, Sheryl Lynch, Michael T. Eadon, Todd C. Skaar
Published 2024Get full text
Artículo Open Access -
4
Evaluation of CYP2C19 Clinical Decision Support Alerts to Guide P2Y12 Inhibitor Prescribing by Ashley N. Springer, Leah A. Alicea, Yemi Gafari, Tayler B. Smith, Sheryl Lynch, Amy M. Breman, Jennelle C. Hodge, Victoria M. Pratt, Nicholas R. Powell, Rolf P. Kreutz, Daniel P. Kobold, Michael T. Eadon, Emma M. Tillman, Tyler Shugg, Todd C. Skaar
Published 2025Get full text
Artículo Open Access